RE:RE:great follow on news....
Youre exactly right, the rubber really hits the road with the double blind / placebo pivotal trials. But this data is very compelling. Everything is pointing to the same conclusion, that the efficacy seen in the animal model translates to humans, and perhaps even more importantly, this lends credence to the likelihood of human efficacy in the other anti-fibrotic related indications... its HUGE. ... This makes the CDN Open label IPF trial results due mid year even more important ....and who knows what surprises are in store.
I thought it interesting to see the normally conservative Cannacord analyst specifically referencing Big Pharma action may be heating up as well.
regardless, short of a broader market meltdown, the company is doing nothign to aid the building short position find a way out. They arent slipping up, in fact they are turning up the heat.... which should theoretically increase institutional buy-in. I would sure love to see the Piper Jaffray analyst or another meaningful US Analyst pick up coverage...